Cargando…

Interleukin-10 suppression enhances T-cell antitumor immunity and responses to checkpoint blockade in chronic lymphocytic leukemia

T-cell dysfunction is a hallmark of B-cell Chronic Lymphocytic Leukemia (CLL), where CLL cells downregulate T-cell responses through regulatory molecules including programmed death ligand-1 (PD-L1) and Interleukin-10 (IL-10). Immune checkpoint blockade (ICB) aims to restore T-cell function by preven...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rivas, J.R., Liu, Y., Alhakeem, S.S., Eckenrode, J.M., Marti, F., Collard, J.P., Zhang, Y., Shaaban, K.A., Muthusamy, N., Hildebrandt, G.C., Fleischman, R.A., Chen, L., Thorson, J.S., Leggas, M., Bondada, S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446094/ https://www.ncbi.nlm.nih.gov/pubmed/33731852 http://dx.doi.org/10.1038/s41375-021-01217-1

Ejemplares similares

Polyamine blockade promotes antitumor immunity
por: Hayes, Candace S, et al.
Publicado: (2014)

PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response?
por: Xu-Monette, Zijun Y., et al.
Publicado: (2017)

Blockade of trans PD-L1 interaction with CD80 augments antitumor immunity
por: Zhang, Yuankun, et al.
Publicado: (2023)

Extracellular vesicle-mediated macrophage activation: An insight into the mechanism of thioredoxin-mediated immune activation
por: Yarana, Chontida, et al.
Publicado: (2019)

Targeted Oral Delivery of Paclitaxel Using Colostrum-Derived Exosomes
por: Kandimalla, Raghuram, et al.
Publicado: (2021)

SIRPα blockade improves the antitumor immunity of radiotherapy in colorectal cancer
por: Ji, Kai, et al.
Publicado: (2023)

Transcription Factor DLX5 As a New Target for Promising Antitumor Agents
por: Timakhov, R.A., et al.
Publicado: (2011)

Pyramidamycins A-D and 3-Hydroxyquinoline-2-carboxamide; Cytotoxic Benzamides from Streptomyces sp. DGC1
por: Shaaban, Khaled A., et al.
Publicado: (2012)

VEGF blockade enhances the antitumor effect of BRAF(V) (600E) inhibition
por: Comunanza, Valentina, et al.
Publicado: (2016)

Antitumor effect of WEE1 blockade as monotherapy or in combination with cisplatin in urothelial cancer
por: Murakami, Kaoru, et al.
Publicado: (2021)

Blockade of novel immune checkpoints and new therapeutic combinations to boost antitumor immunity
por: Archilla-Ortega, Adrià, et al.
Publicado: (2022)

Blockades of effector T cell senescence and exhaustion synergistically enhance antitumor immunity and immunotherapy
por: Liu, Xia, et al.
Publicado: (2022)

Immunoglobulin‐like transcript 2 blockade restores antitumor immune responses in glioblastoma
por: Lorenzo‐Herrero, Seila, et al.
Publicado: (2022)

Radiation Induced Apoptosis of Murine Bone Marrow Cells Is Independent of Early Growth Response 1 (EGR1)
por: Oben, Karine Z., et al.
Publicado: (2017)

Multiple Regulatory Mechanisms Control B-1 B Cell Activation
por: Sindhava, Vishal J., et al.
Publicado: (2012)

Interleukin-21 combined with PD-1 or CTLA-4 blockade enhances antitumor immunity in mouse tumor models
por: Lewis, Katherine E., et al.
Publicado: (2017)

Superagonist IL-15-Armed Oncolytic Virus Elicits Potent Antitumor Immunity and Therapy That Are Enhanced with PD-1 Blockade
por: Kowalsky, Stacy J., et al.
Publicado: (2018)

TIGIT and PD-1 dual checkpoint blockade enhances antitumor immunity and survival in GBM
por: Hung, Alice L., et al.
Publicado: (2018)

Tumor-Directed Blockade of CD47 with Bispecific Antibodies Induces Adaptive Antitumor Immunity
por: Dheilly, Elie, et al.
Publicado: (2018)

TNF blockade uncouples toxicity from antitumor efficacy induced with CD40 chemoimmunotherapy
por: Stone, Meredith L., et al.
Publicado: (2021)

Factors Determining Long-Term Antitumor Responses to Immune Checkpoint Blockade Therapy in Melanoma
por: Loo, Kimberly, et al.
Publicado: (2022)

Adaptive antitumor immune response stimulated by bio-nanoparticle based vaccine and checkpoint blockade
por: Bai, Xuewei, et al.
Publicado: (2022)

Combination of immune checkpoint blockade and targeted gene regulation of angiogenesis for facilitating antitumor immunotherapy
por: Zhan, Jing, et al.
Publicado: (2023)

Blockade of inhibitors of apoptosis (IAPs) in combination with tumor-targeted delivery of tumor necrosis factor-α leads to synergistic antitumor activity
por: Yuan, Z, et al.
Publicado: (2013)

Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti–CTLA-4 antibodies
por: Peggs, Karl S., et al.
Publicado: (2009)

CD73 and PD-L1 dual blockade amplifies antitumor efficacy of SBRT in murine PDAC models
por: Ye, Jian, et al.
Publicado: (2023)

Push and release: TLR9 activation plus STAT3 blockade for systemic antitumor immunity
por: Kortylewski, Marcin, et al.
Publicado: (2014)

T‐cell immunoglobulin mucin 3 blockade drives an antitumor immune response in head and neck cancer
por: Liu, Jian‐Feng, et al.
Publicado: (2017)

Pirfenidone facilitates immune infiltration and enhances the antitumor efficacy of PD-L1 blockade in mice
por: Qin, Wan, et al.
Publicado: (2020)

Targeting Myeloid-Derived Suppressor Cells to Enhance the Antitumor Efficacy of Immune Checkpoint Blockade Therapy
por: Li, Xueyan, et al.
Publicado: (2021)

Blockade of CD47 enhances the antitumor effect of macrophages in renal cell carcinoma through trogocytosis
por: Park, Ha-Ram, et al.
Publicado: (2022)

Combination therapy with T cell engager and PD-L1 blockade enhances the antitumor potency of T cells as predicted by a QSP model
por: Ma, Huilin, et al.
Publicado: (2020)

Feedback loops blockade potentiates apoptosis induction and antitumor activity of a novel AKT inhibitor DC120 in human liver cancer
por: Yang, F, et al.
Publicado: (2014)

Oxidative stress-induced JNK/AP-1 signaling is a major pathway involved in selective apoptosis of myelodysplastic syndrome cells by Withaferin-A
por: Oben, Karine Z., et al.
Publicado: (2017)

Interleukin-6 blockade with tocilizumab in COVID-19: Does it live up to its hype?
por: Kow, C.S., et al.
Publicado: (2021)

Localization and Functional Characterization of the Rat Oatp4c1 Transporter in an In Vitro Cell System and Rat Tissues
por: Kuo, Kuei-Ling, et al.
Publicado: (2012)

Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade
por: Yadavilli, Sapna, et al.
Publicado: (2023)

Intratumoral delivery of RIG-I agonist SLR14 induces robust antitumor responses
por: Jiang, Xiaodong, et al.
Publicado: (2019)

TIM-3 blockade in diffuse intrinsic pontine glioma models promotes tumor regression and antitumor immune memory
por: Ausejo-Mauleon, Iker, et al.
Publicado: (2023)

Central neuraxial blockade for splenectomy in myeloproliferative disease: A word of caution
por: Myatra, SN, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_nqkovs50qr9bu8u55ur7oa27nj